Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Microbes and Infection
|
March 21, 2018
Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
Sagar B Kudchodkar, Hyeree Choi, Emma L Reuschel, et al.
Journal of Hepatology
|
February 24, 2020
IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses
Ji Won Han, Pil Soo Sung, Seon-Hui Hong, et al.
Frontiers in Immunology
|
August 12, 2017
Automated Analysis of Flow Cytometry Data to Reduce Inter-Lab Variation in the Detection of Major Histocompatibility Complex Multimer-Binding T Cells
Natasja Wulff Pedersen, P Anoop Chandran, Yu Qian, et al.
Autism Research : Official Journal of the International Society for Autism Research
|
January 23, 2018
A prospective study of fetal head growth, autistic traits and autism spectrum disorder
Laura M E Blanken, Alena Dass, Gail Alvares, et al.
The New England Journal of Medicine
|
September 15, 2021
Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine
Pablo Tebas, Christine C Roberts, Kar Muthumani, et al.
Pain Research & Management
|
December 21, 2011
The Postoperative Pain Assessment Skills pilot trial
Michael McGillion, Adam Dubrowski, Robyn Stremler, et al.
Nature Communications
|
February 11, 2023
Malodour classification with low-cost flexible electronics
Emre Ozer, Jedrzej Kufel, John Biggs, et al.
JCI Insight
|
May 22, 2020
Robust antibody and cellular responses induced by DNA-only vaccination for HIV
Stephen C De Rosa, Srilatha Edupuganti, Yunda Huang, et al.
Vaccines
|
December 10, 2020
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP<sup>®</sup> DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults
Srilatha Edupuganti, Stephen C De Rosa, Marnie Elizaga, et al.
The Lancet. Infectious Diseases
|
July 29, 2019
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad, Christine C Roberts, Kristin T Mills, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Microbes and Infection
|
March 21, 2018
Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
Sagar B Kudchodkar, Hyeree Choi, Emma L Reuschel, et al.
Journal of Hepatology
|
February 24, 2020
IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses
Ji Won Han, Pil Soo Sung, Seon-Hui Hong, et al.
Frontiers in Immunology
|
August 12, 2017
Automated Analysis of Flow Cytometry Data to Reduce Inter-Lab Variation in the Detection of Major Histocompatibility Complex Multimer-Binding T Cells
Natasja Wulff Pedersen, P Anoop Chandran, Yu Qian, et al.
Autism Research : Official Journal of the International Society for Autism Research
|
January 23, 2018
A prospective study of fetal head growth, autistic traits and autism spectrum disorder
Laura M E Blanken, Alena Dass, Gail Alvares, et al.
The New England Journal of Medicine
|
September 15, 2021
Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine
Pablo Tebas, Christine C Roberts, Kar Muthumani, et al.
Pain Research & Management
|
December 21, 2011
The Postoperative Pain Assessment Skills pilot trial
Michael McGillion, Adam Dubrowski, Robyn Stremler, et al.
Nature Communications
|
February 11, 2023
Malodour classification with low-cost flexible electronics
Emre Ozer, Jedrzej Kufel, John Biggs, et al.
JCI Insight
|
May 22, 2020
Robust antibody and cellular responses induced by DNA-only vaccination for HIV
Stephen C De Rosa, Srilatha Edupuganti, Yunda Huang, et al.
Vaccines
|
December 10, 2020
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP<sup>®</sup> DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults
Srilatha Edupuganti, Stephen C De Rosa, Marnie Elizaga, et al.
The Lancet. Infectious Diseases
|
July 29, 2019
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad, Christine C Roberts, Kristin T Mills, et al.
Page
of 7